Imperial College London

DrBlerinaAhmetaj-Shala

Faculty of MedicineNational Heart & Lung Institute

Advanced Research Fellow
 
 
 
//

Contact

 

+44 (0)20 7351 8137b.ahmetaj

 
 
//

Location

 

Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Kirkby:2020,
author = {Kirkby, N and Gashaw, H and Perikleous, A and Ferreira, P and Ahmetaj-Shala, B and Mitchell, J},
pages = {2491--2492},
publisher = {WILEY},
title = {Novel arginine formulations of celecoxib fully retain COX-2 inhibitory and anti-cancer activity and reverse L-NAME-induced endothelial dysfunction},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530811400015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Kirkby,N
AU - Gashaw,H
AU - Perikleous,A
AU - Ferreira,P
AU - Ahmetaj-Shala,B
AU - Mitchell,J
EP - 2492
PB - WILEY
PY - 2020///
SN - 0007-1188
SP - 2491
TI - Novel arginine formulations of celecoxib fully retain COX-2 inhibitory and anti-cancer activity and reverse L-NAME-induced endothelial dysfunction
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530811400015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -